Fig. 1: Details on centre policy for monitoring and treatment of CMV and EBV reactivations resulting from the survey. | Bone Marrow Transplantation

Fig. 1: Details on centre policy for monitoring and treatment of CMV and EBV reactivations resulting from the survey.

From: Monitoring and management of CMV and EBV after autologous haematopoietic stem cell transplantation for autoimmune diseases: a survey of the EBMT Autoimmune Diseases Working party (ADWP)

Fig. 1

a Methods of detecting CMV or EBV vireamia, b time point of monitoring CMV or EBV, c threshold for pre-emptive therapy (detection in plasma), d threshold for pre-emptive therapy (detection in whole blood), e treatment for reactivation of CMV or EBV.

Back to article page